InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Saturday, 04/04/2015 1:49:24 PM

Saturday, April 04, 2015 1:49:24 PM

Post# of 80868
The problem with a leveraged buyout of too much business is that it may cost us lots of dilution down the road....and that it may not be financed with the lowest interest while Musclepharm is struggling with revenues (as it is right now), and while Capstone Nutrition is struggling with stronger US dollar.

could Musclepharm make it with HIG assisted leveraged buyout?....sure it could, but it's risky for stock price.

It's a matter of high risk high return potential. The potential lies in Musclepharm developing more products and acquire other brands to manufacture.

Is this money flow coming from Colombian drug money as proposed by learningcurve? could be, it will be financed with money from Miami, so there is a theoretical probability..LOL!